Incannex Healthcare (IXHL) Shares Outstanding (2020 - 2026)

Incannex Healthcare (IXHL) posted quarterly Shares Outstanding (Entity) of $13.7 million for Q1 2026, up 1990.88% year-on-year from $654418.0 in Q1 2025, and up 14.27% on a QoQ basis from $12.0 million in Q4 2025.

Incannex Healthcare (IXHL) Shares Outstanding (2020 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Shares Outstanding (Entity) for 7 consecutive years, with $13.7 million the latest figure, recorded in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 1990.88% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 1990.88% YoY) and the FY2025 annual result came in at $1.1 million, up 95.29% from the prior year.
  • Shares Outstanding (Entity) grew to $13.7 million in Q1 2026 per IXHL's latest filing, from $12.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for IXHL reached as high as $13.7 million in Q1 2026 and fell as low as $11667.0 in Q2 2022.
  • A 5-year average of $2.9 million and a median of $588094.0 in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 95.36% — and 2023, when it surged 4435.05%.
  • Year by year, Shares Outstanding (Entity) stood at $21138.0 in 2022, then soared by 2403.09% to $529104.0 in 2023, then advanced by 12.05% to $592841.0 in 2024, then surged by 1919.76% to $12.0 million in 2025, then grew by 14.27% to $13.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $13.7 million, $12.0 million, and $11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 12.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.35 Mn
Dec 31, 2025 11.65 Mn
Sep 30, 2025 10.34 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 654,418.00
Dec 31, 2024 587,481.00
Sep 30, 2024 588,094.00
Jun 30, 2024 538,811.00
Mar 31, 2024 529,104.00
Dec 31, 2023 529,104.00
Sep 30, 2023 529,104.00
Jun 30, 2023 512,823.00
Mar 31, 2023 529,104.00
Dec 31, 2022 21,138.00
Jun 30, 2022 11,667.00
Jun 30, 2021 251,372.00
Jun 30, 2020 16,667.00